WuXi XDC Cayman Inc
2268
Rangering i aksjer
#1886
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Aksjekurs
$8.78
Markedsverdi
$11.12B
Endring (1 dag)
-9.52%
Endring (1 år)
0.57%
Land
CN
Handel WuXi XDC Cayman Inc (2268)
Kategori
Healthcare
Utbyttehistorikk for WuXi XDC Cayman Inc (2268)
WuXi XDC Cayman Inc (aksjesymbol: 2268) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for WuXi XDC Cayman Inc (2268) fra 2026 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| Ikke nok data for de angitte datoene. | ||
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| Ikke nok data for de angitte datoene. | ||
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 63.00% |
US
|
|
| 137.00% |
US
|
|
| 0.00% |
US
|
|
| 10.00% |
CN
|
|
| 60.00% |
US
|
